AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,566 Increased By 157.7 (2.13%)
BR30 24,786 Increased By 749.4 (3.12%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)
World

EU finalises second deal with Pfizer for 300mn vaccine doses

  • The EU's executive has been heavily criticised over the last few weeks after vaccines suppliers, including Pfizer.
Published February 9, 2021

BRUSSELS: The European Union has finalised a deal with Pfizer and BioNTech for the supply of an additional 300 million doses of their COVID-19 vaccine, a European Commission spokesman told Reuters on Monday.

The EU secured 300 million Pfizer doses in November last year and announced a preliminary deal for 300 million more shots on Jan. 8, subject to talks about the terms of the new contract.

"The Commission has adopted the new contract today," the spokesman said.

An official involved in talks with Pfizer said that under the new deal, EU states have already placed orders for 200 million doses to be delivered this year while talks about the timeline for the other 100 million shots were still underway.

"Discussions with the European Commission are ongoing," a spokesman for Pfizer told Reuters on Monday. A spokesman for BioNTech declined to comment.

The EU's executive has been heavily criticised over the last few weeks after vaccines suppliers, including Pfizer, announced delays in deliveries for the first three months of the year.

Comments

Comments are closed.